Evidence map›Paper›PMID 26745855›Full record

ReviewCell adhesion & migration2016

The role of CX3CL1 in fetal-maternal interaction during human gestation.

Elif Kervancioglu Demirci, Lois A Salamonsen, Martin Gauster

Open access · goldAbstract readReview
In one paragraph

Review in Cell adhesion & migration, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Chemokines in Pregnancy.Biomolecules · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Role of chemokines in early pregnancy loss.Experimental and therapeutic medicine · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Elif Kervancioglu Demircia Department of Histology and Embryology , Marmara University School of Medicine , Istanbul , Turkey.
Lois A Salamonsenb Hudson Institute of Medical Research , Clayton , Victoria , Australia.
Martin Gausterd Institute of Cell Biology, Histology and Embryology, Medical University Graz , Austria.
Marmara University · TRMedical University of Graz · ATMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Embryo implantation and subsequent placentation require a fine balanced fetal-maternal cross-talk of hormones, cytokines and chemokines. Amongst the group of chemokines, CX3CL1 (also known as fractalkine) has recently attracted attention in the field of reproductive research. It exists both as membrane-bound and soluble isoforms. On the basis of current experimental evidence, fractalkine is suggested to regulate adhesion and migration processes in fetal-maternal interaction at different stages of human pregnancy. Expressed by uterine glandular epithelial cells, predominantly during the mid-secretory phase of the menstrual cycle, fractalkine appears to prime the blastocyst for forthcoming implantation. After implantation, fractalkine is suggested to regulate invasion of extravillous trophoblasts by altering their expression profile of adhesion molecules. With onset of perfusion of the intervillous space at the end of first trimester, fractalkine present at the apical microvillous plasma membrane of the syncytiotrophoblast may mediate close interaction of placental villi with circulating maternal blood cells.

Indexed as

Maternal-Fetal ExchangeCell MovementChemokine CX3CL1FemaleHumansModels, BiologicalPregnancyTrophoblastsChemokine CX3CL1fetal-maternal cross-talkfractalkineimplantationinvasiontrophoblast

Identifiers

PMID26745855
PMCPMC4853041
OpenAlexW2273299994

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.